{
  "docId": "019de073-ec7b-760b-b9a4-60ceb97e90d9",
  "docSlug": "fef1528177829f37cded553f72a56b72",
  "documentTitle": "AstraZeneca | Results Presentation Deck | 44 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 34,
  "pageCount": 44,
  "prevPage": 33,
  "nextPage": 35,
  "slideType": "appendix_data",
  "function": "present_framework",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The slide uses a custom matrix layout to show drug positioning across patient segments (HER2-high, HR+, HER2-low, etc.) and treatment lines (Early to 3rd-line+).",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de073-ec7b-760b-b9a4-60ceb97e90d9/34",
  "deckHref": "/decks/019de073-ec7b-760b-b9a4-60ceb97e90d9",
  "deckJsonHref": "/decks/019de073-ec7b-760b-b9a4-60ceb97e90d9.json",
  "deckAnchorHref": "/decks/019de073-ec7b-760b-b9a4-60ceb97e90d9#slide-34",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.95,
        "x": 0.03,
        "y": 0.93
      },
      "kind": "disclaimer",
      "text": "HER2-high = human epidermal growth factor receptor 2-high; HR+ = hormone receptor-positive; HER2-low/ultralow = human epidermal growth factor receptor 2-low/ultralow; ET = endocrine therapy; DDR = DNA damage response; HR- = hormone receptor-negative; TROP2+ = trophoblast cell surface antigen 2-directed-positive; IO = immuno-oncology; THP = Taxotere, Herceptin and pertuzumab; CDK4/6i = cyclin-dependent kinase 4/6i; AI = aromatase inhibitor; HRD+ = homologous recombination deficiency-positive; ADC = antibody-drug conjugate; T-DM1 = trastuzumab emtansine; HER2-null = human epidermal growth factor receptor 2-null; Dato-DXd = datopotamab deruxtecan.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ec88930e-38ba-441f-a841-3fc0c8b1f234",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.92,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "framework",
      "text": "Matrix mapping patient segments to treatment lines",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "623f764c-52ec-418d-8c80-4ee68897f502",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.65,
        "x": 0.03,
        "y": 0.13
      },
      "kind": "title",
      "text": "Redefining the classification of breast cancer through monotherapy and combinations",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2849362c-68af-4d8e-9b7b-5e2070842251",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.65,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Oncology: positioned to address the full spectrum of breast cancer",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "60305be3-6280-4e5f-af4f-e619601db973",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "58cd8e76-0472-4a2d-b870-94696bb0d85a",
      "evidence": "framework/instance: Matrix mapping patient segments to treatment lines",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "matrix-nxn",
      "slug": null,
      "matchId": "5b0149d3-5dc8-4970-bc37-b4edeb1a43f1",
      "evidence": "The slide organizes drug positioning across two axes: patient segments (rows) and treatment lines (columns).",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}